Global Market Study on Infectious Diseases Diagnostics: Increasing Demand for Evidence -Based Treatment to Boost Demand for Infectious Diagnostic Testing During Forecast Period
LONDON, Sept. 21, 2016 /PRNewswire/ -- Infectious diseases are caused by pathogens such as bacteria, viruses, fungi, and other parasites, which enter the body directly or indirectly through hosts or other vectors. Diagnostic tests are used to detect and determine the specific disease or condition. Diagnostic tests offer benefits such as rapid and precise results, which assist physicians in the diagnosis and treatment of various diseases.
Persistence Market Research report offers a forecast of the global infectious disease diagnostics market between 2016 and 2024. In terms of value, the market is expected to register a CAGR of 7.0% during the forecast period (2016–2024). This study demonstrates the market dynamics that are expected to influence the current environment and future status of the global infectious disease diagnostics market over the forecast period. It includes key trends, drivers, restraints, and opportunities influencing the growth of the global infectious diseases diagnostics market over the forecast period. Impact analysis of key growth drivers and restraints are included to better equip clients with crystal clear decision-making insights.
The global infectious disease diagnostics market has been segmented on the basis of:
Disease Indication
Techniques
End User
Region
By disease indication, the market is segmented into:
CNS Infection
Meningitis
Brain Abscess
Diarrheal Disease
Shigellosis
Cholera
Enteric/Typhoid Fever
Respiratory Infections
Tuberculosis
Influenza
Bronchitis
Blood Infections
Malaria
Dengue
Infectious Mononucleosis
Others
STDs
Chlamydia
AIDS
Syphilis
Others
The STDs segment is estimated to account for a highest revenue share of 32.2% in 2016 and expected to register a higher CAGR as compared to other disease indication segments during the forecast period.
By technique, the market is segmented into:
ELISA
PCR
Immunoassays
Cell Cultures
Others
Cell cultures segment revenue is expected to expand at highest CAGR of 35.5% over the forecast period.
By end user, the market is segmented into:
Hospitals
Diagnostic Centers
Clinics
Government Organizations
By region/country, the market is segmented into:
North America
U.S.
Canada
Latin America
Brazil
Mexico
Rest of Latin America
Europe
France
Germany
Italy
Spain
U.K.
Russia
Rest of Europe
Asia Pacific (APAC)
China
India
Japan
Australia & New Zealand
ASEAN
Rest of APAC
Middle East & Africa (MEA)
GCC countries
South Africa
Rest of MEA
The APAC infectious disease diagnostics market is estimated to account for 26.5% revenue share in 2016 and expected to dominate the global infectious disease diagnostics market over the forecast period. APAC infectious disease diagnostics market is expected to register a higher CAGR as compared to markets in other regions.
Some key market participants included in the PMR's report are Thermo Fisher Scientific, Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Becton, Dickinson and Company, Hologic, Inc., Bio-Rad Laboratories, Inc. Quidel Corporation, bioMerieux SA, Alere, Inc., and Cepheid.
Download the full report: https://www.reportbuyer.com/product/4158741/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article